Radical multimodality therapy for malignant pleural mesothelioma

Malignant pleural mesothelioma is a cancer that attacks the mesothelial cells that line the pleural cavity in the lungs. This cancer is usually caused by exposure to asbestos and has a poor prognosis. Radical multimodality therapy is a type of treatment that combines several types of therapy, such as surgery, radiotherapy, and chemotherapy, to treat this cancer. In this article, we will discuss more about radical multimodality therapy for malignant pleural mesothelioma.

Radical multimodality therapy is a treatment strategy that aims to extend life expectancy and improve the quality of life of patients with malignant pleural mesothelioma. This therapy involves using several types of treatments to reduce the size of the tumor and slow or stop its growth.

Surgery is one of the main components of radical multimodal therapy. This procedure aims to remove cancer cells that are concentrated in one area, such as in the pleura of the lungs. If malignant pleural mesothelioma has not spread to other parts of the body, then surgery can be an effective treatment option. However, surgery is usually only recommended for patients who are in good health and do not have other health problems that could worsen the results of surgery.

Radiotherapy is also used in radical multimodal therapy to reduce tumor size and slow its growth. The most common radiotherapy technique used to treat malignant pleural mesothelioma is external radiotherapy. In this procedure, X-rays or other high-energy particles are directed at the tumor to kill cancer cells. Radiotherapy can be done before or after surgery.

Chemotherapy is also an important component of radical multimodal therapy. Chemotherapy drugs are given by intravenous infusion or through tablets to kill cancer cells that are present throughout the body. Chemotherapy is often used along with surgery and radiotherapy to treat malignant pleural mesothelioma. However, chemotherapy can also cause unpleasant side effects, such as nausea, vomiting, fatigue, and decreased blood cell counts.

In addition to the three main components, radical multimodality therapy can also include photodynamic therapy and immunotherapy. Photodynamic therapy involves using chemicals that are injected into the body and then activated by light to kill cancer cells. Immunotherapy involves taking drugs that stimulate the immune system to fight cancer cells.

Although radical multimodality therapy can be an effective treatment for malignant pleural mesothelioma, not all patients are suitable for this therapy. Before deciding to undergo radical multimodality therapy, the patient must undergo a thorough evaluation by a medical team trained in cancer treatment. The patient also has to undergo several tests and scans to determine how far the cancer has spread.

In some cases, patients may not be suitable for radical multimodality therapy because the cancer has spread to other parts of the body or because the patient has other health problems that affect their ability to handle aggressive therapy.

However, for patients who are suitable for radical multimodality therapy, this therapy can provide good results. Several studies have shown that patients who undergo radical multimodality therapy have a longer life expectancy than those who only undergo one type of therapy.

However, radical multimodality therapy also has potential side effects. These side effects can vary from patient to patient and depend on the type of therapy given. Some of the common side effects include nausea, vomiting, diarrhea, weight loss, fatigue, and problems with skin and hair.

Overall, radical multimodality therapy can be an effective treatment option for patients with malignant pleural mesothelioma. However, the decision to undergo this therapy should be made carefully after the patient has consulted with a medical team trained in cancer treatment. Patients must also be prepared to deal with potential side effects and undergo long-term treatment to manage their condition.

Share :